Telmiport 40mg Tablet

Description

Information About Telmiport 40mg Tablet

This is a medicine used in the treatment of high blood pressure, also called Hypertension and heart failure. Telmiport 40mg Tablet keeps heart health in check by maintaining blood pressure and preventing the chances of stroke and heart attacks. Diabetic patients also take this medicine to keep their kidney function in check. Telmisartan is its main component. 

Telmiport 40mg Tablet Uses

• In the treatment of Hypertension (high blood pressure)
• In the treatment of Heart failure
• Helps with fever
• Helps prevent heart attack and stroke

Telmiport 40mg Tablet Benefits

• The medicine belongs to the class of angiotensin receptor blockers (ARB). 
• It blockers the chemical messenger that causes blood vessels to get tight, and lets the blood flow smoothly. 
• The process helps lower blood pressure and allows the blood to reach all body parts seamlessly.

How to Use Telmiport 40mg Tablet?

Swallow the tablet as a whole with water, before, after, or during your meals without chewing. Do not crush or break the tablet before consumption. Always take the medicine at the same time and try to maintain a strict schedule.

Telmiport 40mg Tablet Side Effects

The following are the side effects of taking this medicine. These are all temporary and mild. You may not need any medical attention for them. However, just in case you are worried about them, consult your healthcare professional about it. 

• Diarrhea
• Back pain
• Skin ulcer
• Sinus inflammation
• Intermittent claudication
• Upper respiratory tract infection

Caution 

• Do not take this medicine if you have a kidney or liver problem. Discuss it with your healthcare advisor prior to your treatment. 
• Driving under the influence of this drug is harmful as it can affect your ability to focus and blur your vision. 
• Avoid drinking during the treatment. Mixing alcohol with it can be hazardous.  

Frequently Asked Question (FAQs)

Q1. What is the main constituent of the medicine?

Telmisartan is the main component of Telmiport 40mg Tablet. 

Q2.Is the medicine safe for pregnant women?

Telmiport 40mg Tablet may not be safe for pregnant and breastfeeding ladies so speak with your healthcare professional before beginning the treatment. 

Q3. Can I stop the medication, once my BP is in control?

No. Only after your healthcare advisor suggests it after a careful observation, should you stop the medication. Otherwise, no matter how much improvement you see, do not discontinue the treatment. 

Q4.  How long does it take for Telmiport 40mg Tablet to work?

The medicine takes a while to work. Sometimes it can take a few days and even weeks. Stay consistent for the best results.  

Q5. When is the best time to take Telmiport 40mg Tablet?

You can take it at night as well as in the morning but it is best to stay consistent and regular with the dosage. 

References

• Telmisartan [Package Insert]. , Gangtok, Sikkim: Torrent Pharmaceuticals Ltd.; 2022. [Accessed 01 Aug. 2023]. (online) Available from: https://www.torrentian.com/pisheet/Upload/PI_Sheet/3121.pdf 
• Pfeffer MA, Opie LH. Inhibitors of the Renin-Angiotensin-Aldosterone System. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 157.
• Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1322-23.
• Telmisartan. Bracknell, Berkshire: Boehringer Ingelheim Limited; 1998 [revised Nov. 2017]. [Accessed 20 Mar. 2019] (online) Available from: https://www.medicines.org.uk/emc/product/3166/smpc 
• Telmisartan. Ingelheim, Germany: Boehringer Ingelheim Pharma KG; 1998. [Accessed 20 Mar. 2019] (online) Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20850lbl.pdf 
• Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from: https://cdscoonline.gov.in/CDSCO/Drugs 
• Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 19 Mar. 2019] (online) Available from: https://www.scielo.br/j/jped/a/pKPFtLMX4jNH6tTtrqNwb4r/?format=pdf&lang=en 

Marketer details